Evaluation of the safety of tranexamic acid use in pediatric patients undergoing spinal fusion surgery: a retrospective comparative cohort study

Evaluation of the safety of tranexamic acid use in pediatric patients undergoing spinal fusion surgery: a retrospective comparative cohort study

Abstract Background Pediatric spinal fusion may be associated with significant intraoperative blood loss, leading to complications from transfusion, hypoperfusion and coagulopathy. One emerging strategy to mediate these risks is by utilization of the anti-fibrinolytic agent tranexamic acid (TXA). Ho...

Full description

Bibliographic Details
Main Authors: Iryna Ivasyk, Abhinaba Chatterjee, Catherine Jordan, Matthew T. Geiselmann, Peter S. Chang, Hooman Kamel, Sariah Khormaee
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Musculoskeletal Disorders
Subjects:
Tranexamic acid
Txa
Spinal fusion
Antifibrinolytic
Pediatric
Online Access:https://doi.org/10.1186/s12891-022-05604-2

Similar Items

Similar Items